|
DrugPatentWatch concentrates deep knowledge on more than 6,400 small-molecule drugs and 2,300 generic ingredients from 1,700 branded and generic pharmaceutical companies and 700 suppliers, and more than 4,300 active and expired US patents and 74,000 international patents spanning 93 countries and regional patent offices. |
Generic Name: bromocriptine mesylate
Summary for Generic Name: bromocriptine mesylate
| |||||||||||||||
Clinical Trials for: bromocriptine mesylateFed Study of (Parlodel®) Bromocriptine Mesylate Capsules 5 mg Status: Completed Condition: Healthy Fed Study of (Parlodel®) 2.5 mg Bromocriptine Mesylate Tablets Status: Completed Condition: Healthy Effect of Bromocriptine on Left Ventricular Function in Women With Peripartum Cardiomyopathy Status: Recruiting Condition: Peripartum Cardiomyopathy Safety and Tolerability Study of Cycloset in Treatment of Type 2 Diabetes Status: Completed Condition: Type 2 Diabetes Mellitus Vaginal Bromocriptine for Treatment of Adenomyosis Status: Recruiting Condition: Adenomyosis Pramipexole and Bromocriptine on Nonmotor Symptoms of Early Parkinson's Disease Status: Recruiting Condition: Parkinson's Disease QR-Bromocriptine as an Adjunct to Insulin and Metformin in the Treatment of Type 2 Diabetes Status: Completed Condition: Diabetes Mellitus, Type 2 Efficacy and Safety of Cycloset® Compared With Placebo When Added to Metformin Status: Terminated Condition: Type 2 Diabetes Risperidone-Induced Hyperprolactinemia Treated With Bromocriptine Status: Not yet recruiting Condition: Schizophrenia; Hyperprolactinemia Randomized Single-blind Placebo Controlled Comparative Trial of Pramipexole and Bromocriptine in Parkinson's Disease Status: Completed Condition: Parkinson Disease Courtesy of ClinicalTrials.org See more clinical trials for this drug | |||||||||||||||
Glossary
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Type | RLD | Patent No. | Product | Substance | Delist_Flag | Patent Expiration | Patented / Exclusive Use | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Us Pharms Holdings I | PARLODEL | bromocriptine mesylate | TABLET; ORAL | 017962 | Approved Prior to Jan 1, 1982 | RX | Yes | <disabled> | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET; ORAL | 020866 | May 5, 2009 | RX | Yes | 8,137,993 | <disabled> | IMPROVEMENT OF GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETES MELLITUS WHO HAVE ONE OR MORE SPECIFIED CARDIOVASCULAR RISK FACTORS | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET; ORAL | 020866 | May 5, 2009 | RX | Yes | 5,468,755 | <disabled> | IMPROVEMENT OF GLYCEMIC CONTROL IN INDIVIDUALS WITH TYPE 2 DIABETES | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET; ORAL | 020866 | May 5, 2009 | RX | Yes | 5,679,685 | Y | <disabled> | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| The preview shows a limited data set. Complete access is available with a Subscription | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
« Back to Dashboard
DrugPatentWatch Archives
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Connect with Social Media:
Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639
`abc